Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Rongcheng Weicheng Rubber Products Co., Ltd., established on 2013-06-08, The scope of business includes the manufacture and sale of tires,rubber pad,plastic bag,plastic pipe,adhesive tape,Wholesale and retail bearings and accessories,Rubber additives,carbon black,building materials,hardware,steel,Office Supplies,Labor protection supplies,Operating import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

KOKA Lifesciences Co., Ltd. is a company headquartered in Shanghai, China, that manufactures and sells medical devices. The firm was founded in 2018. Ming Ming Wu is currently the CEO of the company.

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Beijing Carditech Medical Equipment Technology Co., Ltd., established on 2018-06-12, Business scope includes technology development,technology transfer,technical consulting,Technical Services;Import and export,Technology Import and Export;Sales of medical devicesIkind,IIkind;Production of Class I Medical Devices;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class II Medical Devices;Production of Class III Medical Devices,The operation of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The First Hospital of Jilin University, part of Jilin University, is a company headquartered in Changchun, China. The firm owns and operates hospital.

Keremage (Beijing) Medical Technology Co., Ltd., established on 2021-11-09, Business scope includes technology development;technical consulting;technology transfer;Technology Promotion;Technical Services;Technology Import and Export;Retail Class I Medical Devices,Class II medical device;Production of Class I Medical Devices;market survey;Import and export;Technology Import and Export;Import and export agency;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class II Medical Devices,Production of Class III Medical Devices,The operation of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nanjing Gulou Hospital is a Chinese private company located in Nanjing. The firm operates as a hospital.

Arthrex GmbH, a subsidiary of Arthrex, Inc., is a German company located in Munich that manufactures orthopedic devices. Stefan Krupp is currently the CEO of the firm.

Weihai Shenghuang Rubber Industry Co., Ltd., established on 2013-12-10, Business scope includes inner tube,Manufacture and sales of gaskets and tire explosion-proof safety devices;Sales of rubber and rubber additives,Import and export of goods and technologies within the filing scope.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Harpoon Medical is a development stage medical device company commercializing a minimally invasive, image-guided surgical tool for beating heart mitral valve repair. The technology was developed in the Division of Cardiac Surgery at The University of Maryland School of Medicine. With the Harpoon device, surgeons can access and repair the mitral valve in a beating heart via a small incision between the ribs without the need for cardiac arrest or cardiopulmonary bypass. The tool enters the left ventricle transapically and inserts “bulky knot” neochords in the leaflet to eliminate mitral valve regurgitation. When introduced to the market, the Harpoon device should transform the traditional open-heart mitral valve surgical procedure from a complex 3-6 hour operation to a 60-minute procedure and reduce the recovery period from weeks to days.